drugset / Trial / NCT05670353

Cannabidiol for the Treatment of Pelvic Pain in Endometriosis (DREAMLAND)

NCT05670353 ↗

Phase 2/3 Terminated 50 enrolled University of Sao Paulo
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this work is to conduct a randomized, double-blind, placebo-controlled clinical trial to assess the efficacy and safety of cannabis extract in women with endometriosis who have already undergone hormonal contraceptive treatment and surgery without satisfactory response.

Timeline

Start
2023-01-03
Primary completion
2024-09-12
Completion
2024-11-20

Outcome

Outcome not reported

Stopped: “The study was prematurely terminated due to the results of the interim analysis conducted, as outlined in the initial project plan.”

Drugs

EvaluationDrugModalityDoseRoute
Subject CBD Unknown 150 mg Oral